Skip to main content
. Author manuscript; available in PMC: 2010 Jan 14.
Published in final edited form as: Eur J Pharmacol. 2008 Dec 3;602(2-3):223–229. doi: 10.1016/j.ejphar.2008.11.044

Table 1.

Inhibition of pancreatic cancer cell lines by the acridine-based compounds.a

Compound
Cell Line 1 2 3 4
BXPC-3 14±4 7±1 12±1 13±1
HupT3 25±3 10±2 11±1 11±3
MiaPaCa2 7±3 1±0.04 4±1 7±2
Panc04.03 12±3 6±1 9±2 10±2
SU86.86 11±1 6±1 9±1 12±2
a

IC50’s (μM) were determined from the MTT assay, which was performed in triplicate.